Masimo (MASI) Divestments (2024 - 2025)
Masimo's quarterly Divestments came in at $287.6 million in Q3 2025, up 3740.51% year-on-year from $7.5 million in Q3 2024, and up 6788.37% quarter-over-quarter from -$4.3 million in Q2 2025.
Masimo has reported Divestments for 2 years, with the latest figure at $287.6 million in Q3 2025.
- For the quarter ending Q3 2025, Divestments rose 3740.51% year-over-year to $287.6 million; the trailing twelve-month figure through Apr 2026 stood at $283.3 million (up 1331.74% YoY), and the FY2026 full-year result was $278.5 million, up 1158.94% from the prior year.
- Divestments for Q3 2025 stood at $287.6 million, up from -$4.3 million in the prior quarter.
- The five-year high for Divestments was $287.6 million in Q3 2025, with the low at -$8.1 million in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2025 | 287.60 Mn |
| Jun 28, 2025 | -4.30 Mn |
| Mar 29, 2025 | -4.80 Mn |
| Dec 28, 2024 | -5.30 Mn |
| Sep 28, 2024 | -7.90 Mn |
| Jun 29, 2024 | -5.00 Mn |
| Mar 30, 2024 | -8.10 Mn |